Group 1 - The core viewpoint of the news highlights the performance and financial metrics of Sai Fen Technology, including stock price increase and trading volume [1] - On November 11, Sai Fen Technology's stock rose by 4.60%, with a trading volume of 102 million yuan and a net financing purchase of 1.7166 million yuan [1] - As of November 11, the total margin balance for Sai Fen Technology was 76.2679 million yuan, accounting for 8.97% of its market capitalization [1] Group 2 - Sai Fen Technology, established on March 16, 2009, is located in the Suzhou Industrial Park and specializes in the research and production of liquid chromatography materials for drug analysis and purification [2] - The company's revenue composition includes 33.10% from industrial purification, 32.65% from fillers, and 16.73% from analytical chromatography, among other segments [2] - For the period from January to September 2025, Sai Fen Technology achieved a revenue of 302 million yuan, representing a year-on-year growth of 38.39%, and a net profit of 93.2118 million yuan, with a growth of 71.07% [2] Group 3 - Since its A-share listing, Sai Fen Technology has distributed a total of 27.9031 million yuan in dividends [3] - As of September 30, 2025, the number of shareholders decreased by 31.51% to 7,159, while the average circulating shares per person increased by 57.01% to 5,933 shares [2][3] - Notably, the Southern Science and Technology Innovation Board 3-Year Open Mixed Fund has exited the top ten circulating shareholders list [3]
赛分科技11月11日获融资买入1140.76万元，融资余额7626.79万元